These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 11501971

  • 1. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
    Lissoni P, Malugani F, Bonfanti A, Bucovec R, Secondino S, Brivio F, Ferrari-Bravo A, Ferrante R, Vigoré L, Rovelli F, Mandalà M, Viviani S, Fumagalli L, Gardani GS.
    J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
    [Abstract] [Full Text] [Related]

  • 2. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline.
    Brivio F, Lissoni P, Rovelli F, Nespoli A, Uggeri F, Fumagalli L, Gardani G.
    Hepatogastroenterology; 2002; 49(44):385-7. PubMed ID: 11995457
    [Abstract] [Full Text] [Related]

  • 3. Anti-angiogenic activity of melatonin in advanced cancer patients.
    Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ.
    Neuro Endocrinol Lett; 2001; 22(1):45-7. PubMed ID: 11335879
    [Abstract] [Full Text] [Related]

  • 4. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
    Nakayama Y, Sako T, Shibao K, Onitsuka K, Nagashima N, Hirata K, Nagata N, Itoh H.
    Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY.
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [Abstract] [Full Text] [Related]

  • 8. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
    Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE.
    Cancer Res; 2000 Jun 01; 60(11):2898-905. PubMed ID: 10850435
    [Abstract] [Full Text] [Related]

  • 10. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
    Salven P, Mänpää H, Orpana A, Alitalo K, Joensuu H.
    Clin Cancer Res; 1997 May 01; 3(5):647-51. PubMed ID: 9815732
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.
    Coskun U, Günel N, Toruner FB, Sancak B, Onuk E, Bayram O, Cengiz O, Yilmaz E, Elbeg S, Ozkan S.
    Neoplasma; 2003 May 01; 50(1):41-6. PubMed ID: 12687277
    [Abstract] [Full Text] [Related]

  • 13. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P, Orpana A, Joensuu H.
    Clin Cancer Res; 1999 Mar 01; 5(3):487-91. PubMed ID: 10100697
    [Abstract] [Full Text] [Related]

  • 14. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD, Landman-Parker J, Arcil B, Coudert MC, Gerota I, Benbunan M, Leverger G, Dosquet C.
    Clin Cancer Res; 2001 Mar 01; 7(3):538-43. PubMed ID: 11297245
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct 01; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
    Nakayama Y, Sako T, Shibao K, Okazaki K, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N, Itoh H.
    Anticancer Res; 2002 Oct 01; 22(4):2437-42. PubMed ID: 12174940
    [Abstract] [Full Text] [Related]

  • 18. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.
    Strauss L, Volland D, Kunkel M, Reichert TE.
    Med Sci Monit; 2005 Aug 01; 11(8):BR280-92. PubMed ID: 16049374
    [Abstract] [Full Text] [Related]

  • 19. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients.
    Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T, Tominaga T.
    Clin Cancer Res; 1996 May 01; 2(5):821-6. PubMed ID: 9816236
    [Abstract] [Full Text] [Related]

  • 20. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K, Christensen IJ, Brünner N, Nielsen HJ.
    Eur J Surg Oncol; 2000 Nov 01; 26(7):657-62. PubMed ID: 11078612
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.